WeissLaw LLP: Apyx Medical Corporation is the Subject of a Legal Investigation

dnrt8765

NEW YORK, July 30, 2020 /PRNewswire/ — WeissLaw LLP, a national class action and shareholders’ rights law firm with offices in New York, California and Georgia, announces an investigation of Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical Corp.,” or the “Company”).


WeissLaw LLP (PRNewsfoto/WeissLaw LLP)

If you own Apyx Medical Corp. shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:

http://www.weisslawllp.com/apyx-medical-corporation/

Or please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

The investigation focuses on possible breaches of fiduciary duty and violations of the Federal securities laws by Apyx Medical Corp.’s Board of Directors.  Notably, in March, Apyx Medical Corp. announced that it had identified material weaknesses in the Company’s internal controls.  As a result, the Company cautioned that financial reports for numerous periods, including the report for the year ended December 31, 2018, the reports for the three and nine months ended September 30, 2018, and the report for the three months ended March 31, 2019, can no longer be relied upon.  On that news, the Company’s shares tumbled from their March 16, 2020 trading high of $5.00 to trade as low as $3.77 per share on March 17, 2020— the day after the announcement. 

WeissLaw is investigating whether Apyx Medical Corp.’s Board breached its fiduciary duties to the Company and its shareholders by failing to implement and maintain an adequate system of internal controls and by failing to exercise sufficient oversight over the Company’s operations.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information) please email us at stockinfo@weisslawllp.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/weisslaw-llp-apyx-medical-corporation-is-the-subject-of-a-legal-investigation-301103609.html

SOURCE WeissLaw LLP

Next Post

Expedia Group Q2 2020 Earnings Transcript and Recording Available on Company’s IR Site

The MarketWatch News Department was not involved in the creation of this content. Expedia Group, Inc. (NASDAQ: EXPE) experienced technical difficulties today with the webcast portion of its second quarter earnings call due to a webcast provider outage. In addition to the earnings release, the call transcript and recording are […]